Ncardia

Business Services · Netherlands · 51-200 Employees

View Company Info for Free

Overview

Headquarters

Galileiweg 8, Leiden, South Holland, 233...

Phone Number

+31 713322230

Revenue

$17.2 Million

Industry

Business Services Research & Development

About Ncardia

Ncardia specializes in providing human induced pluripotent stem cell (iPSC) contract research organization (CRO) services and cell models aimed at drug discovery, safety pharmacology, and disease modeling. Their offerings include custom iPSC cell services, ready-to-use assays, and a diverse range of iPSC-derived cell products, particularly in cardiovascular and neural applications. Targeting pharmaceutical and biotechnology companies, Ncardia supports the development of innovative therapies through advanced iPSC technology and robust screening platforms. By leveraging their expertise, clients can make informed decisions and accelerate the development of breakthrough therapies.Explore more
Ncardia's Social MediaSIC Code 87,873NAICS Code 54,541Show more
Illustration of an envelope

Ncardia Tech Stack

A closer look at the technologies used by Ncardia

Top Business Services Companies

Frequently Asked Questions Regarding Ncardia

What is Ncardia's official website?
Ncardia's official website is www.ncardia.com
What is Ncardia's Revenue?
Ncardia's revenue is $17.2 Million
What is Ncardia's SIC code?
Ncardia's SIC: 87,873
What is Ncardia's NAICS code?
Ncardia's NAICS: 54,541
How many employees does Ncardia have?
Ncardia has 51-200 employees
What industry does Ncardia belong to?
Ncardia is in the industry of: Business Services, Research & Development
What technology does Ncardia use?
Some of the popular technologies that Ncardia uses are: DocuSign, HubSpot, Adobe Typekit, Microsoft 365
How do I contact Ncardia?
Ncardia contact info: Phone number: +31 713322230 Website: www.ncardia.com
What does Ncardia do?

Ncardia specializes in providing human induced pluripotent stem cell (iPSC) contract research organization (CRO) services and cell models aimed at drug discovery, safety pharmacology, and disease modeling. Their offerings include custom iPSC cell services, ready-to-use assays, and a diverse range of iPSC-derived cell products, particularly in cardi... ovascular and neural applications. Targeting pharmaceutical and biotechnology companies, Ncardia supports the development of innovative therapies through advanced iPSC technology and robust screening platforms. By leveraging their expertise, clients can make informed decisions and accelerate the development of breakthrough therapies.Read More

What are Ncardia social media links?
Ncardia Linkedin page Ncardia Twitter page Ncardia Facebook page
Who invested in Ncardia?
Ncardia has 7 investors including Vesalius Biocapital Partners, SRIW, The SFPI-FPIM and Vesalius Biocapital Partners.
Is Ncardia a public company?
Ncardia is private company therefore does not currently have an official ticker symbol
See more information about Ncardia

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.